Neogen names Andrea Wainer to board as director James P. Tobin retires
Neogen said director James P. Tobin will retire from its Board effective May 31, 2025, and that Andrea Wainer will join the Board effective June 1, 2025. The filing describes no financial results or guidance, so the change is a board composition update rather than a change in reported performance.
Key points
- James P. Tobin, a director since 2016, retires effective May 31, 2025 and currently chairs the Governance and Sustainability Committee.
- James C. Borel, Board Chair, will serve as interim chair of the Governance and Sustainability Committee until a successor is appointed.
- Andrea Wainer joins the Board as a Class II director effective June 1, 2025, and will serve on the Governance and Sustainability and Science, Technology, and Innovation Committees.
- Ms. Wainer previously served as Executive Vice President, Rapid and Molecular Diagnostics at Abbott Laboratories.
The filing
Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 13, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.